Blog

13 January, 2020

2019, a new year of “progress” and “remarkable progress” for pharmaceutical innovation

The European agency EMA gives green light to 30 new drugs and the US FDA, to 48 Hematology and oncology account for more than a third […]
10 January, 2020

The keys that can turn Spain into a reference for biomedical research

Source: www.20minutos.es Our country is one of the best conditions to host biomedical and pharmaceutical research projects, both national and international. In 1886, scientists Oskar Minkowski […]
8 January, 2020

The pharmaceutical industry accelerates against lung cancer, the one with the highest mortality in Spain

One in five clinical trials in Oncology in our country investigates this type of tumor, which causes 22,000 deaths per year The available treatments have tripled […]
11 December, 2019

“We have put the name of Vall d’Hebron on the map of world oncology”

  Source: www.immedicohospitalario.es Such a high percentage of participation in clinical research studies has no one. The Vall d’Hebron Institute of Oncology (VHIO) is a research […]
27 November, 2019

Andalusian high school students are interested in drug R&D

The Maternal and Child Hospital of Malaga hosted on Wednesday a new edition of the day ‘Bringing science closer to schools. Drug research and development ’, […]
20 November, 2019

Farmaindustria reinforces the collaboration to promote clinical research in Spain

Meeting with hospital pharmacists to exchange knowledge and experience between industry and professionals to promote trials It was agreed to establish a mixed working group to […]
15 November, 2019

#WeWontRest until we beat Alzheimer’s disease – together

Source: www.epfia.eu Unlocking the mystery behind Alzheimer’s disease and dementia and improving care for people require new types of partnership. As we navigate uncertain waters, we […]
11 November, 2019

The pharmaceutical industry reaffirms its commitment to R&D in rare diseases

The number of new treatments available against rare pathologies has multiplied by 20 in Europe since 2000 The industry insists on collaboration with governments and health […]
7 November, 2019

The pharmaceutical industry already invests more than 660 million euros a year in clinical research in Spain

It is one of the keys that explain why Spain has become one of the countries in Europe with better conditions to develop clinical trials of […]
5 November, 2019

Investment in R&D of the pharmaceutical industry, a value for the whole society

Experts from the Weber Foundation and Farmaindustria clear some doubts about drug spending and analyze research challenges. Source: www.farmaindustria.es The pharmaceutical sector is high risk; For […]
18 October, 2019

The pharmaceutical industry has in the R&D phase 140 new medicines against mental disorders

To the suffering of patients and relatives there are costs that in the European Union equal 4% of the GDP of the member countries This Thursday […]
16 October, 2019

The pharmaceutical industry strengthens its commitment to pediatric clinical research and already promotes nine out of ten trials in this field

Farmaindustria participates in Santiago de Compostela in the II National Meeting of the Spanish Network of Pediatric Clinical Trials Source: www.farmaindustria.es The research and development of […]
3 October, 2019

More hospitals aspire to become CAR-T centers

Source: IM Medical Publimas Digital s.l. The Ministry of Health and the Autonomous Communities have met to assess the suitability of new candidates to administer this […]
30 September, 2019

New drugs in cardiovascular disease, a success story

The pharmaceutical industry currently has about 600 new treatments against developing cardiovascular pathologies This Sunday, September 29, World Heart Day is celebrated Source: www.farmaindustria.es Cardiovascular diseases […]
16 September, 2019

The pharmaceutical industry develops in Spain almost 200 clinical trials on lung cancer

The European Week of this tumor has been celebrated, of which almost 30,000 new cases are diagnosed each year in Spain Despite being one of the […]
10 September, 2019

Pharmaceutical companies reaffirm their commitment to research and access to innovation in Spain

Predictability, adequate taxation and imagination in the search for solutions, within the framework of a constant dialogue with the Administration, keys to ensure the advancement of […]
29 July, 2019

A global and long-term analysis of the medication is essential to consider all its health, economic and social benefits

Impact on patient health, health system management and economic growth, among the most relevant effects The director of the Department of Pharmaceutical Studies, Pedro Luis Sánchez, […]
22 July, 2019

Each year 15,000 patients participate in clinical trials promoted by the pharmaceutical industry in Spain

Each year 15,000 patients participate in clinical trials promoted by the pharmaceutical industry in Spain Source: www.farmaindustria.es Spain has become one of the reference countries in […]
18 July, 2019

“Spanish society should know that participating in a clinical trial is something beneficial”

Farmaindustria participates in the program ‘Es la Tarde de Dieter’, by EsRadio, in a debate on clinical research in Spain Source: www.farmaindustria.es Clinical trials, which are […]
16 July, 2019

Pharmaceutical companies, managers, healthcare professionals and researchers seek to strengthen the excellence of clinical trials in Spain

Farmaindustria brings together in Madrid more than 120 experts to continue advancing in an area in which our country is already an international benchmark Source: www.farmaindustria.es […]
24 June, 2019

The pharmaceutical industry facilitates the participation of more than 150,000 patients in clinical trials in the last 12 years

More than half of the clinical research with medicines is done in the early stages, the most complex Strengthen the participation of patients in all stages […]
17 June, 2019

Private healthcare already participates in half of clinical trials

Specifically, they collaborate in 48.5 percent of them according to Farmaindustria data Source: www.sanidadprivada.publicacionmedica.com Between 2004 and 2018, private health centers have participated in 1,431 clinical […]
11 June, 2019

Spain takes a step forward in clinical research in early phases in pediatrics and rare diseases

Farmaindustria is working on a new online Guide for Early Phase Clinical Research Units for the benefit of the research community The University Hospital La Paz […]
30 May, 2019

CAR-T therapy, future option to improve the treatment of multiple myeloma

The day ‘Controversies in patients with myeloma: candidate or not to haematopoietic transplantation and in relapse’, organized by the Jiménez Díaz Foundation and the San Carlos […]
27 May, 2019

The resignation of May dilates the concern of the pharmaceutical companies before a Brexit without agreement

After almost three years at the head of the Government, Theresa May has announced that she will present her resignation on June 7. Source: www.consalud.es This […]
24 May, 2019

Clinical trials, key to developing new drugs and valuable for the economy and cost savings health

Source: www.farmaindustria.es Each new drug that reaches patients has one behind or, in general, several successful clinical trials. The clinical trial, which in the vast majority […]
24 May, 2019

Savings of 10,000 euros / patient for the clinical trials of the industry

Source: www.redaccionmedica.com The clinical trials promoted by the pharmaceutical industry “are not only vital to develop new treatments for patients, but also play an important role […]
24 May, 2019

Conference “University research and regulatory compliance of the RGPD”

Source: www.farmaindustria.es Scientific research in general, and biomedical research in particular, are activities of general public interest, given the benefits they bring to society as a […]
2 May, 2019

An atlas at the individual cell level will improve precision medicine in breast cancer

It reveals the diversity of cancer and immune cells in the tumor ecosystem, with the aim of better selecting treatments. Source: immedicohospitalario.es Investigadores University of Zurich […]
29 April, 2019

The protection of intellectual property, key to the development of new medicines

Source: immedicohospitalario.es The regulatory ecosystem for the protection of intellectual property in Europe works. The set of laws, regulations and incentives developed by the European Union […]
12 September, 2023

Improving patient access to innovative medicines and boosting R&D and manufacturing in Spain are the main priorities of the pharmaceutical industry

“We must take advantage of the opportunity provided by the Spanish Presidency of the Council of the EU to include health, medicines and the innovative pharmaceutical […]
25 July, 2023

The rise of combination therapies in cancer opens up an opportunity for patients, but requires improved access procedures

Over the next five years, the number of cancer treatments consisting of more than one drug will double, with 68 authorisations expected to be granted The […]
18 July, 2023

The 22nd Meeting of the Spanish Pharmaceutical Industry will focus on the reform of European legislation and its impact on Spain

The forum, organised by the Menéndez Pelayo International University (UIMP) and Farmaindustria, will be held on 7 and 8 September in Santander Patient representatives, drug authorities, […]
10 July, 2023

The pharmaceutical industry, one of the most value-added sectors in Europe

The sector invests 41.5 billion euros in research and directly employs some 840,000 people 300 billion, exports ¤565 billion and contributes ¤175 billion to the EU-27 […]
4 July, 2023

Pharmaceutical companies set a record for investment in collaborations with the healthcare system through R&D and support for lifelong learning

Last year, the sector contributed 313 million euros for organisations and healthcare professionals to participate in research and development activities for new treatments For the eighth […]
27 June, 2023

Spain, a global power in clinical trials

One out of every three tests carried out in Europe takes place in Spain. Investment has grown by 5.3% annually since 2011, to almost 800 million […]
19 June, 2023

“We must bring clinical trials closer to the patient’s home, and for this, research in primary care is vital”

The associate director of Clinical and Translational Research at Farmaindustria, Amelia Martín Uranga, explained at a forum organised by the POP that work is already underway […]
30 May, 2023

XVI ANNUAL CONFERENCE OF BIOMEDICAL RESEARCH TECHNOLOGY PLATFORMS

On 23 May, part of the Distefar team attended the biomedical research technology platform. The opening was a conference by Juan José Vaquero, entitled “Strategy for […]
25 May, 2023

“The availability of oncology drugs needs to improve, as only 57% of those approved in Europe are available”

The director of Farmaindustria’s Access department analyses the challenges in the access of these patients to pharmaceutical innovation at a conference of the Spanish Society of […]
22 May, 2023

Clinical trials, hope for today’s patients and new medicines for tomorrow’s patients

International Clinical Trials Day commemorates the importance of clinical trials every 20 May Clinical trials advance medicine and address unmet medical needs Source: farmaindustria.es In the […]
11 May, 2023

“The increase in international competitiveness and digitalisation will require more investment to ensure that Spain remains at the forefront of biomedical R&D”

The Deputy Director General of Farmaindustria, Javier Urzay, recalls that this is a key moment to define the country’s strategy in research to face the new […]
8 May, 2023

“Bringing clinical trials closer to the patient’s home is a challenge in which the public and private sectors must go hand in hand”

This measure allows for greater participation and the inclusion of a more diverse population, which improves the scientific quality of the studies, as highlighted by Farmaindustria’s […]